Gastrointestinal Bleeding: Antiplatelets and Anticoagulants

Gastrointestinal Bleeding: Second Edition

Volumn , Issue , 2012, Pages 29-40

  Sung, Joseph ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Antiplatelet agents, cause of UGIB, LGIB; Aspirin induced GI bleeding; Clopidogrel, inhibitor of ADP induced; Double antiplatelet agent therapy; GI bleeding, antiplatelets and anticoagulants; H. pylori infection; NSAIDs, warfarin, corticosteroid use; Oral and intravenous anticoagulants, warfarin and heparin; Selective COX 2 inhibitor (Coxib); Upper GI bleeding, in aspirin users

Indexed keywords

EID: 84885704995     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444398892.ch3     Document Type: Chapter

References (30)

1. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of anti-platelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002 12;324(7329):71-86.
2. Hayden M, Pignone M, Phillips C, Mulrow C. Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2002;136(2):161-72.
3. Pearson TA, Blair SN, Daniels SR, et al. AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee. Circulation 2002;106:388-91.
4. Sanmuganathan PS, Ghahramani P, Jackson PR, et al. Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials. Heart 2001;85(3):265-71.
5. McQuaid KR, Laine L. System review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials. Am J Med 2006;119:624-38.
6. Derry S, Loke YK. Risk of gastrointestinal hemorrhage with long term use of aspirin: meta-analysis. BMJ 2000;32:1183-7.
7. Lanas A, Bajador E, Serrano P, et al. Nitrovasodilators, low-dose aspirin, other nonsteroidal antiinflammatory drugs and the risk of upper gastrointestinal bleeding. N Engl J Med 2000;343:834-9.
8. Slattery J, Warlow CP, Shorrock CJ, Langman MJ. Risk of gastrointestinal bleeding during secondary prevention of vascular events with aspirin - analysis of gastrointestinal bleeding during the UK-TIA trial. Gut 1995;37:509-11.
9. Kelly JP, Kaufman DW, Jurgelon JM, Sheehan J, Koff RS, Shapiro S. Risk of aspirinassociated major upper gastrointestinal bleeding with enteric coated or buffered product. Lancet 1996;348:1413-16.
10. Patrono C, Garcia Rodriguez LA, Landolfi R, Baigent C. Low-dose aspirin for the prevention of atherothrombosis. N Engl J Med 2005;353:2373-83.
11. Nielsen GL, Sorensen HT, Mellemkjoer L, et al. Risk of hospitalization resulting from upper gastrointestinal bleeding among patients taking corticosteroids: a register-based cohort study. Am J Med 2001;111:541-5.
12. Sorensen HT, Mellemkjaer I, Blot WH, et al. Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin. Am J Gastroenterol 2000;95:2218-24.
13. Laine L, Maller ES, Yu C, Quan H, Simon T. Ulcer formation with low-dose entericcoated aspirin and the effect of COX-2 selective inhibition: a double-blind trial. Gastroenterology 2004;127:395-402.
14. Schnitzer TJ, Bumester GR, Mysler E, et al. Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET): randomized controlled trial. Lancet 2004;364:665-74.
15. Chan FKL, Chung SCS, Suen BY, et al. Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infectionwhoare taking low-dose aspirin or naproxen. NEJM 2001;344:967.
16. Lai KC, Lam SK, Chu KM, et al. Lansoprazole for the prevention of recurrence of ulcer complications from long-term low-dose aspirin use. N Engl J Med 2001;346:2033-8.
17. Chan FK, Ching JY, Hung LC, et al. Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding. N Engl J Med 2005;352:238-44.
18. Lai KC, Chu KM, Hui WM, et al. Esomeprazole with aspirin versus clopidogrel for prevention of recurrent gastrointestinal ulcer complications. Clin Gastroenterol Hepatol 2006;4:860-5.
19. Hella J, Dall M, Andries A, Andersen BS, et al. Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study. Br Med J 2006;333:726-30.
20. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. Bhatt DL, Scheiman J, Abraham NS, et al. American College of Cardiology Foundation; American College of Gastroenterology; American Heart Association. Am J Gastroenterol 2008;103:2890-2907.
21. ACCR/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risk of antiplatelet therapy and NSAID use. Abraham NS, Haltky MA, Antman EM, et al. Am J Gastroenterol 2010;105:2533-49.
22. Sung JJ, Lau JY, Ching JY, Wu JC, Lee YT, Chiu PW, et al. Continuation of low-dose aspirin therapy in peptic ulcer bleeding: a randomized trial. Ann Intern Med 2010;152:1-9.
23. Gilard M, Arnaud B, Cornily JC, Le Gal G, Lacut K, Le Calvez G, et al. Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study. Am Coll Cardiol 2008 22;51(3):256-60.
24. O'Donoghue ML, Braunwald E, Antman EM, et al. Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton pump inhibitor: an analysis of two randomized trial. Lancet 2009;374:989-97. Chapter 3: Gastrointestinal Bleeding: Antiplatelets and Anticoagulants 39
25. Juurlink DN, Gomes T, Ko DT, Szmitko PE, Austin PC, Tu JV, et al.Apopulation-based study of the drug interaction between proton pump inhibitors and clopidogrel. CMAJ 2009 31;180(7):713-18.
26. Ho PM, Maddox TM, Wang L, Fihn SD, Jesse RL, Peterson ED, et al. Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome. JAMA 2009 4;301(9):937-44.
27. Bhatt DL, Cryer BL, Contant CT, et al. Clopidogrel with or without omperazole in coronary artery disease. N Engl J Med 2010;363:1909-17.
28. Shireman TI, Howard PA, Kresowik TF, Ellerbeck EF. Combined anticoagulantantiplatelet use and major bleeding events in elderly atrial fibrillation patients. Stroke 2004;35(10):2362-7.
29. Baradarian R, Ramdhaney S, Chapalamadugu R, Skoczylas L, Wang K, Rivilis S, et al. Early intensive resuscitation of patients with upper gastrointestinal bleeding decreases mortality. Am J Gastroenterol 2004;99:619-22.
30. Laine L. Gastrointestinal bleeding with low-dose aspirin: what is the risk? Aliment Pharma Ther 2006;24:897-908. 40 Part I: General Approach to Upper and Lower GI Bleeding